Neuromuscular dysfunction is prevalent in childhood #CancerSurvivors. Rodwin et al find that it continues to increase post-therapy and is associated with adverse health and socioeconomic outcomes. https://t.co/4JzooVieeB https://t.co/VK5cSyTdVR
Neuromuscular dysfunction is prevalent in childhood #CancerSurvivors. Rodwin et al find that it continues to increase post-therapy and is associated with adverse health and socioeconomic outcomes. https://t.co/uel7YezXR4 https://t.co/na9kOc3Bfm
Neuromuscular dysfunction is prevalent in childhood #CancerSurvivors. Rodwin et al find that it continues to increase post-therapy and is associated with adverse health and socioeconomic outcomes. https://t.co/iEFvRrPbJP https://t.co/G07LYynF5H
RT @YalePediatrics: New research led by Dr. Rozalyn Rodwin & Dr. Nina Kadan-Lottick in @CEBP_AACR shows neuromuscular dysfunction is preval…
New research led by Dr. Rozalyn Rodwin & Dr. Nina Kadan-Lottick in @CEBP_AACR shows neuromuscular dysfunction is prevalent in #ChildhoodCancer survivors, increasing adverse health and socioeconomic outcomes. @SmilowCancer @YaleMed @YNHH @YalePediatrics
RT @YalePediatrics: New research led by Dr. Rozalyn Rodwin & Dr. Nina Kadan-Lottick in @CEBP_AACR shows neuromuscular dysfunction is preval…
New research led by Dr. Rozalyn Rodwin & Dr. Nina Kadan-Lottick in @CEBP_AACR shows neuromuscular dysfunction is prevalent in #ChildhoodCancer survivors, increasing adverse health and socioeconomic outcomes. @SmilowCancer @YaleMed @YNHH @YalePediatrics
RT @YalePediatrics: New research led by Dr. Rozalyn Rodwin & Dr. Nina Kadan-Lottick in @CEBP_AACR shows neuromuscular dysfunction is preval…
RT @YalePediatrics: New research led by Dr. Rozalyn Rodwin & Dr. Nina Kadan-Lottick in @CEBP_AACR shows neuromuscular dysfunction is preval…
RT @YalePediatrics: New research led by Dr. Rozalyn Rodwin & Dr. Nina Kadan-Lottick in @CEBP_AACR shows neuromuscular dysfunction is preval…
New research led by Dr. Rozalyn Rodwin & Dr. Nina Kadan-Lottick in @CEBP_AACR shows neuromuscular dysfunction is prevalent in #ChildhoodCancer survivors, increasing adverse health and socioeconomic outcomes. @SmilowCancer @YaleMed @YNHH @YalePediatrics
Longitudinal evaluation of neuromuscular dysfunction in long-term survivors of childhood cancer. https://t.co/iSrZPH6GTc
RT @YalePediatrics: New research led by Dr. Rozalyn Rodwin & Dr. Nina Kadan-Lottick in @CEBP_AACR shows neuromuscular dysfunction is preval…
RT @YalePediatrics: New research led by Dr. Rozalyn Rodwin & Dr. Nina Kadan-Lottick in @CEBP_AACR shows neuromuscular dysfunction is preval…
New research led by Dr. Rozalyn Rodwin & Dr. Nina Kadan-Lottick in @CEBP_AACR shows neuromuscular dysfunction is prevalent in #ChildhoodCancer survivors, increasing adverse health and socioeconomic outcomes. @SmilowCancer @YaleMed @YNHH @YalePediatrics